Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin

Ageing Research Reviews
Diane SlatsSebastiaan Overeem

Abstract

AD, sleep and circadian rhythm physiology display an intricate relationship. On the one hand, AD pathology leads to sleep and circadian disturbances, with a clear negative influence on quality of life. On the other hand, there is increasing evidence that both sleep and circadian regulating systems exert an influence on AD pathology. In this review we describe the impairments of both sleep regulating systems and circadian rhythms in AD and their link to clinical symptoms, as this may increase knowledge on appropriate diagnosis and adequate treatment of sleep problems in AD. Furthermore we discuss how sleep regulating systems, and especially neurotransmitters such as melatonin and hypocretin, may affect AD pathophysiology, as this may provide a role for lack of sleep and circadian rhythm deterioration in the onset of AD.

Associated Clinical Trials

References

Sep 11, 1992·Brain Research·D F SwaabJ A van de Nes
Mar 1, 1992·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R J Reiter
Jul 1, 1991·Brain Pathology·M GoedertR A Crowther
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Oct 1, 1991·Journal of Geriatric Psychiatry and Neurology·C P Pollak, D Perlick
Jan 1, 1990·International Psychogeriatrics·R P FriedlandE Koss
Jul 1, 1990·Journal of Gerontology·M V VitielloR K Ries
Jul 1, 1989·Survey of Ophthalmology·B Katz, S Rimmer
Oct 1, 1987·The Journal of Pharmacy and Pharmacology·K SurrallD J Padwick
Feb 1, 1989·Biological Psychiatry·D L BliwiseW C Dement
Jan 1, 1988·Physiology & Behavior·S S CampbellJ C Hrubovcak
Apr 1, 1985·Biological Psychiatry·C F ReynoldsD Martin
Feb 1, 1982·Journal of the American Geriatrics Society·P N PrinzC J Gerber
Apr 1, 1995·Journal of Geriatric Psychiatry and Neurology·J T LittleL Volicer
Jun 1, 1994·Physiology & Behavior·P J MurphyK P Wright
Jan 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E Holsboer-TrachslerR Spiegel
Jan 12, 1996·Science·J E SherinC B Saper
Jul 1, 1995·Neurobiology of Aging·J N ZhouD F Swaab
Sep 26, 1997·Alzheimer Disease and Associated Disorders·C C ColendaP B Rosenquist
Dec 24, 1997·Journal of Biological Rhythms·J ArendtS Deacon
Jan 4, 1998·Journal of Molecular Neuroscience : MN·W Song, D K Lahiri
Dec 31, 1997·Journal of Neuropathology and Experimental Neurology·P BoznerM A Pappolla
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Apr 29, 1998·The Journal of Biological Chemistry·M PappollaJ Ghiso
Feb 12, 1999·Journal of Neuropathology and Experimental Neurology·E G StopaA Satlin
Sep 14, 1999·Journal of Geriatric Psychiatry and Neurology·S M McCurryE B Larson

❮ Previous
Next ❯

Citations

Nov 6, 2013·Pharmacology & Therapeutics·M DreslerF Holsboer
Dec 4, 2012·Antioxidants & Redox Signaling·Melissa WilkingNihal Ahmad
Jul 17, 2013·International Journal of Molecular Sciences·Li LinQing Tian
Nov 12, 2014·Nature Reviews. Neurology·Aleksandar VidenovicSebastiaan Overeem
Mar 25, 2014·Journal of Neuroinflammation·Ian A Clark, Bryce Vissel
Jan 18, 2016·Journal of Neuroscience Methods·Jenny TownhillAnne E Rosser
Dec 3, 2014·Ageing Research Reviews·Joshua P NixonJennifer A Teske
Mar 19, 2014·Food Chemistry·Patrick RigaÁngel Gil-Izquierdo
Jan 8, 2015·Frontiers in Neurology·Milena BanoSara Montagnese
Mar 23, 2017·Current Neurology and Neuroscience Reports·Yumna Saeed, Sabra M Abbott
Aug 19, 2016·Therapeutic Advances in Psychopharmacology·Vesile Altınyazar, Nefati Kiylioglu
Feb 10, 2018·Sleep·Martin OlssonHenrik Zetterberg
Jan 20, 2018·Alzheimer Disease and Associated Disorders·Ángela Milán-Tomás, Colin M Shapiro
Dec 28, 2017·Journal of Alzheimer's Disease : JAD·Dong-Wan ChenChang-Yue Gao
Nov 6, 2018·Annals of Neurology·Audrey GabelleUNKNOWN Multi-Domain Intervention Alzheimer's Prevention Trial study groups
Jan 1, 2019·Rejuvenation Research·Karolin YanarUfuk Çakatay
Jan 23, 2019·The Journal of Comparative Neurology·Alessia MontesanoPaolo de Girolamo
Sep 13, 2019·Alzheimer's Research & Therapy·Young Min ChoeUNKNOWN KBASE Research Group
Nov 25, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Peter CroninPaula Desplats
Aug 29, 2019·Current Alzheimer Research·Carla PetrellaCinzia Severini
Feb 18, 2020·Journal of Alzheimer's Disease : JAD·Claudio LiguoriFabio Placidi
Aug 14, 2020·Biomolecules·Dongmei ChenTae Ho Lee
Nov 24, 2016·Nature·C Loren Buck
Apr 30, 2017·Journal of Alzheimer's Disease : JAD·Alice HardingSim K Singhrao
Aug 28, 2020·Alzheimer's Research & Therapy·Jana ThomasJurgen A H R Claassen
Oct 8, 2020·Journal of Neuroinflammation·Shaghayegh SadeghmousaviNima Rezaei
Nov 18, 2020·Sleep·Andrey KostinMd Noor Alam
May 3, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yajing LiuHaiqun Xie

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Basal Forebrain & Food Avoidance

Neurons in the basal forebrain play specific roles in regulating feeding. Here are the latest discoveries pertaining to the basal forebrain and food avoidance.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Related Papers

Experimental Gerontology
S R Pandi-PerumalD P Cardinali
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
Sebastiaan OvereemGert Jan Lammers
Lancet Neurology
Shahrad Taheri, Emmanuel Mignot
Neurologic Clinics
Suresh Kotagal
© 2021 Meta ULC. All rights reserved